Cell cultures is an expensive technology with constant needs for foetal bovine serum and various growth factors. This has been a big limiting factor for bio-pharma, nutraceuticals, medical research, drug testing and cellular agriculture.
This technology produces cultured cells and cultured serum containing various growth factors. The technology can handle any types of animal cells such as mammals (including human), fish, crustaceans, and so on.
The technology comprises of connected pump, oxygenator, dialyzer, and bioreactors containing the cells from each organ such as liver and pancreas. The culture medium circulates through the bioreactors and other components, just like blood circulation. The culture medium picks up growth factors from each bioreactor containing each organ cells. This way, the system simulates an animal body to produce conditioned medium containing a mixture of functional compounds such as peptides, lipids and active cytokines.
This ultra low-cost cell culture is achieved by not requiring any external addition of foetal bovine serum or growth factors, but only the basal medium such as DMEM. Even for the basal medium, low-grade (i.e. food grade) materials such as industrial amino acids can be used
The system in principle, is capable of culturing any types of cells from any species. This means, it can produce anything made by living things such as omega fatty acids, cells, tissues, growth factors, serum, hormones, meat, organs and such. Its astounding versatility makes it ideal for clients wanting to produce premium food (e.g. foie gras, tenderloin, etc.), cosmetics, supplements, functional ingredients, pharmaceuticals, and any other biological and agricultural products.
One of the many products by this system includes cultured serum designed for anti-aging skincare. This alone has $50B market size. The ultimate application of the technology, cell-cultured meat, has total $2T addressable market.
This technology can produce animal cell derived compounds that was otherwise impractically expensive. Examples include serum, peptides, lipids and cytokines.
The system cultures cells at ultra-low cost without serum or externally added growth factors. This has a number of implications from production cost, consumer acceptance, regulatory clearance and intrinsic biological safety.